The contraceptive reliability of the levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena®, Bayer HealthCare, Berlin, Germany) is well established, with efficacy comparable to female sterilization [1–3], but with the added advantage of rapid return of fertility upon removal.